Table 2 Clinical and laboratory data of patients according to LV dysfunction after MI.
From: TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis
Variables | LVEF > 40% (14) | LVEF ≤ 40% (14) | p-value |
|---|---|---|---|
Female (%) | 37.5 (5) | 21.4 (3) | 0.403 |
Age (years) | 57.1 ± 7 | 60.8 ± 8.1 | 0.206 |
BMI (kg/m2) | 28.1 ± 5.1 | 28.6 ± 4.6 | 0.795 |
Family history of MI (%) | 71.4 (10) | 71.4 (10) | 0.999 |
Smoking (%) | 64.3 (9) | 50.0 (7) | 0.445 |
Alcohol intake (%) | 71.4 (10) | 50.0 (7) | 0.246 |
Physical activity (%) | 71.4 (10) | 71.4 (10) | 0.999 |
Systolic pressure (mmHg) | 120.0 ± 18.5 | 120.8 ± 14.7 | 0.598 |
Diastolic pressure (mmHg) | 77.92 ± 8.91 | 80.0 ± 10.0 | 0.754 |
Time since last MI (months) | 12.6 ± 24.1 | 47.9 ± 56.4 | 0.023 |
EF (%) | 57.9 ± 7.5 | 32.2 ± 5.4 | <0.001 |
Diabetes (%) | 28.6 (4) | 71.4 (10) | 0.012 |
Obesity (%) | 21.4 (3) | 42.9 (6) | 0.420 |
Glucose (mg/dL) | 102.1 ± 17.2 | 124.3 ± 39.8 | 0.159 |
Total cholesterol (mg/dL) | 156.6 ± 46.1 | 137.2 ± 29.5 | 0.598 |
HDL cholesterol (mg/dL) | 36.17 ± 7.7 | 33.5 ± 10.8 | 0.488 |
LDL cholesterol (mg/dL) | 89 ± 34.1 | 33.5 ± 10.8 | 0.413 |
Triglycerides (mg/dL) | 171.3 ± 107.0 | 185.2 ± 116.4 | 0.597 |
Urea (mg/dL) | 37.8 ± 11.3 | 57.9 ± 35.6 | 0.214 |
Creatinine (mg/dL) | 0.9 ± 0.3 | 1.35 ± 0.7 | 0.101 |
ALT (U/L) | 34.2 ± 18.35 | 33.7 ± 16.0 | 0.870 |
AST (U/L) | 27.9 ± 13.0 | 27.0 ± 8.6 | 0.806 |
